Wang Zuo
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 5
- Inflammasome and immune disorders 5
- Peroxisome Proliferator-Activated Receptors 4
- Kruppel-like factors research 3
- Surgery 13
- Cholesterol and Lipid Metabolism 6
- Co-authors
- Shiyuan Wu (5 shared papers)Zhaolin Zeng (4 shared papers)Guohua Li (1 shared paper)Dangheng Wei (11 shared papers)Lushan Liu (9 shared papers)Zhi‐Sheng Jiang (5 shared papers)Jun Tao (5 shared papers)Juan Peng (4 shared papers)
In The Last Decade
Wang Zuo
45 papers receiving 1.6k citations
Wang Zuo's Hit Papers
Peers
Comparison fields: 5 of 106
- Nephrology 119
- Cancer Research 234
- Immunology 320
- Molecular Biology 895
- Surgery 330
Countries citing papers authored by Wang Zuo
This map shows the geographic impact of Wang Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Zuo more than expected).
Fields of papers citing papers by Wang Zuo
This network shows the impact of papers produced by Wang Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Zuo. The network helps show where Wang Zuo may publish in the future.
Co-authors
The 25 scholars most cited alongside Wang Zuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of pyroptosis in cardiovascular disease Hit paper breakdown → | 2018 | 391 |
| 2 | New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway Hit paper breakdown → | 2017 | 235 |
| 3 | 2018 | 125 | |
| 4 | 2020 | 113 | |
| 5 | 2016 | 76 | |
| 6 | 2016 | 61 | |
| 7 | 2015 | 55 | |
| 8 | 2018 | 45 | |
| 9 | 2015 | 43 | |
| 10 | 2014 | 38 | |
| 11 | 2020 | 37 | |
| 12 | 2014 | 35 | |
| 13 | 2021 | 33 | |
| 14 | Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages. | 2004 | 30 |
| 15 | 2004 | 30 | |
| 16 | 2019 | 29 | |
| 17 | 2020 | 29 | |
| 18 | 2014 | 28 | |
| 19 | 2011 | 23 | |
| 20 | 2017 | 21 |
About Wang Zuo
Wang Zuo is a scholar working on Molecular Biology, Surgery, Immunology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (6 papers), Epigenetics and DNA Methylation (5 papers), Inflammasome and immune disorders (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Autophagy in Disease and Therapy (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Pregnancy and preeclampsia studies (3 papers) and Kruppel-like factors research (3 papers). The work is most often cited by research in Nephrology (119 citations), Cancer Research (234 citations), Immunology (320 citations), Molecular Biology (895 citations) and Surgery (330 citations). Wang Zuo has collaborated with scholars based in China, Taiwan and Canada. Frequent co-authors include Shiyuan Wu, Zhaolin Zeng, Guohua Li, Dangheng Wei, Lushan Liu, Zhi‐Sheng Jiang, Jun Tao, Juan Peng, Zhang Hai and Zhi‐Han Tang. Their work appears in journals such as DNA and Cell Biology, Journal of Cellular Physiology, Clinica Chimica Acta, International Journal of Molecular Medicine and Annals of Biomedical Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.